A chest widening composition and its application
Through the preparation of wide-breast composition, the wide-breast composition using steam distillation to extract asarum oil and other ingredients has been solved, and the existing efficacy and safety problems of the treatment of stroke have been significantly improved, and the cerebral ischemia injury and cognitive function have been significantly improved. , which reduces mortality and neuronal apoptosis, and achieves effective treatment and prevention of stroke.
Patent Information
- Application Number
- CN202311461513.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2020-11-11
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2040-11-11
AI Technical Summary
Existing drugs for treatment and prevention of stroke lack effectiveness, especially for mild and moderate acute ischemic stroke, and adverse reactions to the cardiovascular and central nervous system, lack safe and effective neuroprotective agents.
Using a wide-breast composition, a new drug is prepared for the treatment and prevention of stroke by steam distillation. Oil 10-30, sandalwood oil 50-80, galangal oil 20-40, pineapple oil 8-22, borneol 10-30, extracted by steam distillation and added anhydrous sodium sulfate powder to dehydrate, and filtration to obtain a volatile oil composition .
The wide-thoracic composition significantly improves cerebral ischemia injury in mice and gerbils, reduces cerebral infarction volume, reduces mortality, improves cognitive dysfunction, reduces neuronal apoptosis, and has good neuroprotective effects, avoids cardiovascular and central Adverse reactions to the nervous system.
Smart Images

Figure CN117379513B_ABST
Abstract
Description
[0001] This application is a divisional application of application number 202011253153.9, application date November 11, 2020, and invention name "Use of wide-chest compositions in the preparation of drugs for the treatment and / or prevention of stroke". Technical Field
[0002] The present invention relates to the technical field of traditional Chinese medicines, and in particular to a chest-widening composition and an application thereof, in particular to an application of the chest-widening composition in preparing a medicine for treating and / or preventing cerebral stroke. Background Art
[0003] Kuanxiong aerosol is a Chinese patent medicine. Its drug standard is listed in the 2015 edition of the Chinese Pharmacopoeia, pages 1411-1413. It is composed of asarum oil, sandalwood oil, galangal oil, piper longum oil, and borneol. It has the effect of regulating qi and relieving pain, and is currently used to relieve angina pectoris. On this basis, new uses of the Kuanxiong composition are continued to be studied to expand its application field.
[0004] "Cerebral stroke" is also known as "stroke" and "cerebral vascular accident" (CVA). It is an acute cerebrovascular disease, a group of diseases caused by sudden rupture of brain blood vessels or blood vessel blockage that prevents blood from flowing into the brain, causing brain tissue damage, including ischemic and hemorrhagic stroke. The incidence of ischemic stroke is higher than that of hemorrhagic stroke, accounting for 60% to 70% of the total number of strokes. Occlusion and stenosis of the internal carotid artery and vertebral artery can cause ischemic stroke, mostly in people over 40 years old, more male than female, and severe cases can cause death. The mortality rate of hemorrhagic stroke is high. Surveys show that urban and rural stroke has become the leading cause of death in my country and the leading cause of disability among Chinese adults. Stroke is characterized by high incidence, high mortality and high disability rate. Different types of stroke have different treatment methods. Due to the lack of effective treatment methods, prevention is currently considered the best measure, among which hypertension is an important controllable risk factor for stroke.
[0005] Neuroprotective agents are a class of drugs that can reduce stress responses under pathological conditions of the brain, reduce inflammatory damage, promote nerve cell regeneration and repair, prevent, treat stroke, and improve stroke prognosis. Neuroprotective treatment has the effects of shortening ischemic time, reducing intracellular Ca2+ and Na+ concentrations, blocking the action of glutamate, inhibiting free radicals, inhibiting PARP activity, blocking caspase activity, blocking leukocyte adhesion, changing cell membrane fluidity, and reducing tissue temperature. Therefore, ideal neuroprotective drugs can reduce the mortality rate of stroke patients, improve patients' neurological function and prognosis; have multiple effects such as combating free radicals, calcium overload, and inducible NO synthase (iNOS); have a good benefit-risk ratio, especially avoiding adverse reactions in the cardiovascular system, blood system, and heat stroke nervous system; avoid cerebral vasodilation, bleeding and other adverse reactions; have the function of promoting brain metabolism; have mild toxic and side effects; no need to identify the cause before use, making early treatment possible. Summary of the invention
[0006] The purpose of the present invention is to provide a new medicine for treating and / or preventing cerebral stroke.
[0007] One of the purposes of the present invention is to provide a use of a wide chest composition in preparing a drug for treating and / or preventing stroke;
[0008] Another object of the present invention is to provide the use of the wide chest composition in preparing a drug for treating and / or preventing mild to moderate acute ischemic stroke.
[0009] Another object of the present invention is to provide the use of the wide chest composition in the preparation of a neuroprotective drug for stroke. ;
[0010] The weight proportions of the raw materials in the chest-widening composition are as follows: 10-30 parts of asarum oil, 50-80 parts of sandalwood oil, 20-40 parts of galangal oil, 8-22 parts of piper longum oil, and 10-30 parts of borneol.
[0011] The asarum oil, sandalwood oil, galangal oil and piper longum oil are all volatile oils extracted separately from corresponding medicinal materials through steam distillation.
[0012] The relative density of the asarum oil is 0.962-1.062; the relative density of the sandalwood oil is 0.944-0.984; the relative density of the galangal oil is 0.873-0.913; and the relative density of the longum longum oil is 0.832-0.892.
[0013] The method of described steam distillation extraction is:
[0014] The corresponding medicinal materials are crushed into coarse powder, distilled water of 4-12 times the total weight of the medicinal materials is added, and extraction is performed by steam distillation for 4-10 hours, the upper essential oil is collected, and then anhydrous sodium sulfate powder is added for dehydration, and the powder is filtered to obtain the product.
[0015] As shown in the experimental examples, the broad-chested composition of the present invention has an effect of resisting brain damage caused by MCAO in mice, and can significantly improve cognitive dysfunction caused by global cerebral ischemia in gerbils. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 is the effect of the wide-chest composition in the mouse middle cerebral artery occlusion model;
[0017] Figure 2 is the effect of the broad-chested composition on the results of the novel object recognition test in the gerbil BCCAO model;
[0018] Figure 3 The effect of wide-chest composition on apoptosis of SH-SY5Y neurons induced by oxygen-glucose deprivation. DETAILED DESCRIPTION
[0019] The present invention is further described below by way of examples. It should be understood that the examples of the present invention are intended to illustrate the present invention rather than to limit the present invention. Simple modifications to the present invention made according to the essence of the present invention all fall within the scope of protection claimed in the present invention.
[0020] Embodiment 1:
[0021] The composition of each raw material in the wide chest composition is:
[0022] 100g of asarum oil, 500g of sandalwood oil, 200g of galangal oil, 80g of piper longum oil, and 100g of borneol.
[0023] The asarum oil, sandalwood oil, galangal oil and piper longum oil are all volatile oils extracted from the corresponding medicinal materials by steam distillation. The relative density of the asarum oil is 0.962-1.062; the relative density of the sandalwood oil is 0.944-0.984; the relative density of the galangal oil is 0.873-0.913; and the relative density of the piper longum oil is 0.832-0.892.
[0024] The method of described steam distillation extraction is:
[0025] Take the corresponding medicinal materials and grind them into coarse powder. Add distilled water 4 times the total weight of the medicinal materials, extract by steam distillation for 4 hours, collect the upper essential oil, then add anhydrous sodium sulfate powder for dehydration, and filter to obtain the product.
[0026] Embodiment 2:
[0027] The composition of each raw material in the wide chest composition is:
[0028] 300g of asarum oil, 800g of sandalwood oil, 400g of galangal oil, 220g of piper longum oil, and 300g of borneol.
[0029] The asarum oil, sandalwood oil, galangal oil and piper longum oil are all volatile oils extracted from the corresponding medicinal materials by steam distillation. The relative density of the asarum oil is 0.962-1.062; the relative density of the sandalwood oil is 0.944-0.984; the relative density of the galangal oil is 0.873-0.913; and the relative density of the piper longum oil is 0.832-0.892.
[0030] The method of described steam distillation extraction is:
[0031] Take the corresponding medicinal materials and grind them into coarse powder. Add distilled water 12 times the total weight of the medicinal materials, extract by steam distillation for 10 hours, collect the upper essential oil, then add anhydrous sodium sulfate powder for dehydration, and filter to obtain the product.
[0032] Embodiment 3:
[0033] The composition of each raw material in the wide chest composition is:
[0034] 200g of asarum oil, 600g of sandalwood oil, 300g of galangal oil, 150g of piper longum oil, and 200g of borneol.
[0035] The asarum oil, sandalwood oil, galangal oil and piper longum oil are all volatile oils extracted from the corresponding medicinal materials by steam distillation. The relative density of the asarum oil is 0.962-1.062; the relative density of the sandalwood oil is 0.944-0.984; the relative density of the galangal oil is 0.873-0.913; and the relative density of the piper longum oil is 0.832-0.892.
[0036] The method of described steam distillation extraction is:
[0037] Take the corresponding medicinal materials and grind them into coarse powder. Add distilled water 6 times the total weight of the medicinal materials, extract by steam distillation for 9 hours, collect the upper essential oil, then add anhydrous sodium sulfate powder for dehydration, and filter to obtain the product.
[0038] Embodiment 4:
[0039] The composition of each raw material in the wide chest composition is:
[0040] 150g of asarum oil, 700g of sandalwood oil, 250g of galangal oil, 200g of piper longum oil, and 160g of borneol.
[0041] The asarum oil, sandalwood oil, galangal oil and piper longum oil are all volatile oils extracted from the corresponding medicinal materials by steam distillation. The relative density of the asarum oil is 0.962-1.062; the relative density of the sandalwood oil is 0.944-0.984; the relative density of the galangal oil is 0.873-0.913; and the relative density of the piper longum oil is 0.832-0.892.
[0042] The method of described steam distillation extraction is:
[0043] Take the corresponding medicinal materials and grind them into coarse powder. Add distilled water 8 times the total weight of the medicinal materials, extract by steam distillation for 8 hours, collect the upper essential oil, then add anhydrous sodium sulfate powder for dehydration, and filter to obtain the product.
[0044] Embodiment 5:
[0045] The composition of each raw material in the wide chest composition is:
[0046] 240g of asarum oil, 600g of sandalwood oil, 120g of galangal oil, 170g of piper longum oil, and 220g of borneol.
[0047] The asarum oil, sandalwood oil, galangal oil and piper longum oil are all volatile oils extracted from the corresponding medicinal materials by steam distillation. The relative density of the asarum oil is 0.962-1.062; the relative density of the sandalwood oil is 0.944-0.984; the relative density of the galangal oil is 0.873-0.913; and the relative density of the piper longum oil is 0.832-0.892.
[0048] The method of described steam distillation extraction is:
[0049] Take the corresponding medicinal materials and grind them into coarse powder. Add distilled water of 9 times the total weight of the medicinal materials, extract by steam distillation for 7 hours, collect the upper essential oil, then add anhydrous sodium sulfate powder for dehydration, and filter to obtain the product.
[0050] Embodiment 6:
[0051] Wide chest aerosol
[0052] The wide-chest aerosol is produced in accordance with the standards of the Chinese Pharmacopoeia 2015 edition, Part I, pages 1411-1413.
[0053] The steam distillation extraction method of each medicinal material is as follows:
[0054] Take the corresponding medicinal materials and grind them into coarse powder. Add distilled water 10 times the total weight of the medicinal materials, extract by steam distillation for 6 hours, collect the upper essential oil, then add anhydrous sodium sulfate powder for dehydration, and filter to obtain the product.
[0055] Example 7
[0056] Wide chest drops
[0057] The composition of each raw material in the wide chest composition is:
[0058] 180g of asarum oil, 660g of sandalwood oil, 300g of galangal oil, 160g of piper longum oil, and 200g of borneol.
[0059] The asarum oil, sandalwood oil, galangal oil and piper longum oil are all volatile oils extracted from the corresponding medicinal materials by steam distillation. The relative density of the asarum oil is 0.962-1.062; the relative density of the sandalwood oil is 0.944-0.984; the relative density of the galangal oil is 0.873-0.913; and the relative density of the piper longum oil is 0.832-0.892.
[0060] The method of described steam distillation extraction is:
[0061] Take the corresponding medicinal materials and grind them into coarse powder. Add distilled water of 9 times the total weight of the medicinal materials, extract by steam distillation for 5 hours, collect the upper essential oil, then add anhydrous sodium sulfate powder for dehydration, and filter to obtain the product.
[0062] Sandalwood oil, galangal oil, asarum oil and piper longum oil are mixed, and borneol is added and heated to dissolve as an oil phase; HS15 and the oil phase are mixed uniformly under stirring to obtain a mixture of the oil phase and HS15; NaCl and potassium sorbate are dispersed in water to obtain an aqueous phase, and the final concentration of NaCl is about 0.7% (w / v); the aqueous phase is added dropwise to the mixture of the oil phase and HS15 under stirring; the mixture is heated to 50° C. under stirring, and then cooled to 20° C.; the pH is adjusted to 5.5-6.5, and water is added to make up to volume.
[0063] Example 8: Drug efficacy experiment
[0064] The wide chest composition used in the experiment is wide chest drops
[0065] The composition of each raw material in the wide chest composition is:
[0066] 180g of asarum oil, 660g of sandalwood oil, 300g of galangal oil, 160g of piper longum oil, and 200g of borneol.
[0067] The asarum oil, sandalwood oil, galangal oil and piper longum oil all meet the standards of pages 1411-1413 of Part I of the 2015 edition of the Chinese Pharmacopoeia.
[0068] Statistical analysis
[0069] The experimental data were plotted and analyzed using GraphPad Prism 5.0 software, and the results were expressed as mean ± standard error (Mean ± SEM). One-way ANOVA was used to compare the groups and evaluate the overall variance difference. If the F value P>0.05 indicated that the data variance was homogeneous, LSDt-test was used to compare the data among multiple groups. If the F value P<0.05 indicated that the data variance was unequal, Dunnett's T3 was used to compare the data among multiple groups. P<0.05 for the comparison of the data among the groups was considered to be statistically significant.
[0070] 1. The overall experimental process is as follows:
[0071] 1. Effect of Kuanxiong drops in the mouse middle cerebral artery embolism model
[0072] (1) Preparation and administration of the middle cerebral artery occlusion mouse model
[0073] Male C57BL / 6 mice were anesthetized with isoflurane. The cortical cerebral blood flow corresponding to the middle cerebral artery (MCA) was monitored by Doppler laser blood flow meter. The mouse scalp was cut open to expose the anterior bregma, and the front end of the laser Doppler blood flow meter fiber was fixed on the animal skull, 2 mm behind the anterior bregma and 6 mm to the right of the midline. The mouse was placed in a supine position, the right common carotid artery was exposed and separated, the distal end was ligated, and the proximal end was clamped with a hemostat. A small incision was made with microsurgical scissors, and a 6-0 nylon monofilament suture with a blunt tip was inserted into the right internal carotid artery for about 10 mm to block the origin of the MCA, resulting in a middle cerebral artery occlusion (MCA occlusion, MCAO) model. The cerebral blood flow meter data was observed, and if the blood flow value decreased by less than 80%, the animal was excluded.
[0074] One or three hours after surgery, the wide-chest drops were dripped into the nasal cavity of the mice. The positive drug was butylbenpeptide (6.5 mg / kg, intraperitoneal injection), and the administration time was the same as that of the wide-chest drops.
[0075] (2) Experimental process
[0076] C57 male mice underwent MCAO to induce focal acute cerebral infarction. One hour after surgery, 0.5, 1.5, and 5.0 μl / mouse of Kuanxiong drops were administered nasally. N-butylphthalide (NBP) was administered by intraperitoneal injection (6.5 mg / kg). After 24 hours, (A) animal mortality, (B) cerebral infarction volume, and (C) neurological symptom score were observed. n = 10 animals in each group; compared with the model group (Model) *P < 0.05, one-way ANOVA was used for statistical analysis. Model: model group; NBP: N-butylphthalide group; KX: Kuanxiong drops group.
[0077] (3) Experimental conclusion: Within the above dosage range, Kuanxiong drops reduced the acute mortality of mice induced by MCAO to 50% and reduced the mortality to 20% ( Figure 1 A). Within the dose range of 0.5-5.0 μl / mouse, the effect on cerebral infarction volume showed a Bell-shape-like dose correlation. The dose of 1.5 μl / mouse could significantly reduce the cerebral infarction volume, and its efficacy was comparable to that of NBP ( Figure 1B). Neurological symptoms were scored and it was found that Kuanxiong Drops significantly improved neurological symptoms and reduced neurological symptom scores within the dose range of 1.5-5.0 μl / mouse; a decreasing trend was observed in the butylphthalide group, but there was no statistically significant difference compared with the model group ( Figure 1 C).
[0078] 2. Effect of wide chest drops on the ability to recognize new objects in the BCCAO model of gerbils
[0079] (1) Preparation and drug administration of bilateral common carotid artery occlusion model in gerbils
[0080] Mongolian gerbils, male, weighing 55-65g, were anesthetized with pentobarbital and shaved on the head. After disinfection, a midsagittal incision was made to expose the anterior bregma. With the anterior bregma as the origin, a 0.5mm diameter optical fiber was fixed 1.5mm behind the anterior bregma and 2.0mm to the left of the midline. The animal was turned over and fixed in the dorsal position. The optical fiber was connected to the laser Doppler blood flowmeter to record the blood flow in the cerebral cortex. The gerbils were fixed on the operating table in a supine position. A midline incision was made in the neck to expose the bilateral common carotid arteries and clamp them with micro-arterial clamps. After 5 minutes, the clamps were released, blood supply was restored, and the neck incision was sutured to prepare a global cerebral ischemia-reperfusion injury model. The sham operation group was operated in the same way as above except that the artery was not clamped.
[0081] Immediately after surgery, the sham operation group and the model group were instilled with 3.0 μL / side of blank nasal drops into the bilateral nasal cavities of the gerbils using a microinjector. Immediately after surgery, the wide chest drops group was instilled with 3.0 μL / side of wide chest drops into the bilateral nasal cavities of the gerbils. Immediately after surgery, the positive drug group was intraperitoneally injected with 6.5 mg / kg of butylphthalide injection. After the gerbils woke up, they were put back in the cage and fed, and the drugs were administered at the same time for 3 or 7 consecutive days until they were killed.
[0082] (2) Behavioral testing of novel object recognition
[0083] The test environment of this experiment was a white opaque plastic box without a lid (length, width and height were all 45 cm), and the objects used for detection were 2 yellow cones and 2 blue diamond cones, which were used as old objects and new objects respectively. After 3 or 7 consecutive days of drug administration, the new object recognition behavior test was performed on gerbils.
[0084] 24 hours before the experiment, each gerbil was placed in a white opaque plastic box to adapt to the environment for 15 minutes. The formal experiment was divided into two stages. The first stage was the adaptation stage. Two yellow cones were placed in relative positions in the box (object 1 and object 2), and then the gerbil was placed in the middle of the two objects, allowing the gerbil to move freely for 10 minutes. The second stage was the test stage. Object 1 remained unchanged, and object 2 was replaced with a blue diamond cone, and then the gerbil was put in again to explore for 5 minutes. There was a 30-minute interval between the first and second stages. After each gerbil was taken out of the box, the object and the plastic box were wiped with 75% alcohol to eliminate the smell of the gerbil staying on the object and the box. All experimental processes were video recorded and saved, and the detection time of the gerbil on each object was recorded. According to the total exploration time of gerbils on object 1 (yellow cone) (T1) and the total exploration time on object 2 (blue diamond cone) (T2) in the second stage, the discrimination index (DI) of gerbils for new objects was calculated. The calculation formula was DI = (T2-T1) / (T2+T1)*100%.
[0085] (3) Experimental process
[0086] The bilateral common carotid artery ligation (BCCAO) model of gerbils was used to simulate global cerebral ischemia. After BCCAO, novel object recognition experiment was performed to detect the memory ability of animals.
[0087] After continuous administration for (A) 3 days or (B) 7 days, the discrimination index of novel object recognition in gerbils was detected and analyzed. (Compared with the Model group, *P<0.05, **P<0.01; n=6-7 in A; n=9-10 in B). One-way ANOVA was used for statistical analysis. Sham: sham operation group; Model: model group; NBP: butylphthalide group; KX: wide chest drops group.
[0088] (4) Experimental conclusion: Compared with the model group, there was no significant difference in the novel object identification index of gerbils in the NBP group and the wide chest drops group ( Figure 2 A). After 7 days of continuous administration, a new object recognition experiment was conducted, and the data of the wide chest drops group and the model group showed statistically significant differences ( Figure 2 B). The above results indicate that wide-chest drops can effectively reduce the weakening of novel object recognition ability after global cerebral ischemia in gerbils.
[0089] 3. Effect of Kuanxiong drops on apoptosis of SH-SY5Y neurons induced by oxygen-glucose deprivation
[0090] (1) SH-SY5Y cell culture and oxygen-glucose deprivation-reperfusion treatment
[0091] SH-SY5Y cells were cultured in DMEM medium + 10% fetal bovine serum, 37°C, 5% CO 2. Oxygen-glucose deprivation (OGD) treatment: The cell culture medium was replaced with sugar-free DMEM, and the cells were placed in a Billups-Rothenberg hypoxic tank filled with a mixture of 95% N 2 and 5% CO 2 for 7 minutes. After the ventilation (25L / min×5min) was stopped, the sealed hypoxic tank was placed in an incubator. After the OGD was completed, the culture medium was replaced with sugar-containing DMEM (4.5g / L), and this time was recorded as the start of reperfusion. The wide chest drops were diluted in the culture medium in proportion, and incubated with the cells after reperfusion until the next experimental operation.
[0092] (2) Cell viability assay
[0093] The SH-SY5Y cells were OGD for 3 hours and reperfused for 12 hours. Thiazolyl blue was added to the cultured cells (final concentration was 0.5 mg / ml), incubated at 37°C in the dark for 4 hours, the culture medium was removed, DMSO was added, and the cells were placed on a shaker for 15 minutes before reading using an ELISA reader.
[0094] (3) Cell apoptosis detection
[0095] The SH-SY5Y cells were OGD for 3 hours and reperfused for 6 hours. The cells were fixed with 4% paraformaldehyde (pH = 7.4) at room temperature for 1 hour, rinsed with PBS; the membrane was permeabilized with 0.1% TritonX-100in0.1% sodium citrate incubated on ice for 2 minutes; TUNEL reagent was added and incubated at 37°C in the dark for 1 hour. After sealing, the confocal microscope was used to take pictures and the number of TUNEL-positive cells was counted. Apoptosis (%) = number of TUNEL-positive cells / total number of cells * 100%.
[0096] (4) Experimental process: The SH-SY5Y neural cell line was treated with oxygen-glucose deprivation reperfusion (OR) for 3 hours, and then reperfused and incubated with wide-chest drops at different dilutions. (A) Cell viability was detected by MTT method after 12 hours of treatment; (B) TUNEL method was used to detect cell apoptosis rate and (C) cell apoptosis rate was counted. (D) Cells were collected after 6 hours of treatment, and the expression levels of apoptosis-related proteins Bcl-2 and Bax were detected. The above experiments were repeated at least 3 times, *P<0.05, **P<0.01, ***P<0.001, compared with the indicated groups, and the statistical method used was one-way ANOVA. OR: oxygen-glucose deprivation reperfusion; KX: wide-chest drops
[0097] (5) Experimental conclusion: The neuroprotective effect of wide chest drops was tested using the SH-SY5Y neural cell model treated with oxygen-glucose deprivation reperfusion (OR). MTT assay showed that KX drugs diluted in the range of 1:10000-1:5000 could significantly reverse the decrease in cell viability caused by OR, and showed a dose-dependent relationship ( Figure 3 A). The TUNEL method was further used to detect the level of cell apoptosis. The results showed that OR significantly increased the rate of cell apoptosis, while Kuanxiong drops significantly reversed the occurrence of cell apoptosis ( Figure 3 BC). To preliminarily clarify the anti-apoptotic mechanism of Kuanxiong drops, the expression levels of mitochondrial apoptosis-related proteins Bcl-2 and Bax were detected. The results showed that Kuanxiong drops could significantly upregulate Bcl-2 levels after OR and significantly reduce Bax levels. The above results indicate that Kuanxiong drops can reduce OR-induced SH-SY5Y neuronal apoptosis and thus play a neuroprotective role.
[0098] 2. Conclusion
[0099] 1. Kuanxiong drops have anti-acute focal cerebral ischemia effects in mice, and the administration time window is within 1 hour after the onset of ischemia.
[0100] 2. Kuanxiong drops can significantly improve cognitive dysfunction caused by global cerebral ischemia in gerbils.
[0101] 3. Kuanxiong drops can significantly reduce the rate of neuronal apoptosis caused by oxygen-glucose deprivation-reperfusion.
Claims
1. Use of a Chinese medicine composition in the preparation of a neuroprotective drug or a drug for improving cognitive dysfunction caused by global cerebral ischemia, characterized in that: The Chinese medicine composition is made of the following raw materials: sandalwood oil, galangal oil, asarum oil, piper longum oil, and borneol; The dosage of each raw material is: 660g sandalwood oil, 300g galangal oil, 180g asarum oil, 160g longan oil, and 200g borneol; The sandalwood oil, galangal oil, asarum oil and piper longum oil are all volatile oils extracted from the corresponding medicinal materials by steam distillation. The method of steam distillation for separate extraction is: take the corresponding medicinal materials and grind them into coarse powder, add distilled water of 9 times the total weight of the medicinal materials, extract by steam distillation for 5 hours, collect the upper essential oil, then add anhydrous sodium sulfate powder for dehydration, and filter to obtain the essential oil; The preparation method of the traditional Chinese medicine composition comprises the following steps: mixing sandalwood oil, galangal oil, asarum oil and piper longum oil, adding borneol and heating to dissolve as an oil phase; mixing HS15 and the oil phase uniformly under stirring to obtain a mixture of the oil phase and HS15; dispersing NaCl and potassium sorbate in water to obtain an aqueous phase, so that the final concentration of NaCl is 0.7%; adding the aqueous phase dropwise to the mixture of the oil phase and HS15 under stirring; heating to 50°C under stirring, and then cooling to 20°C; adjusting the pH to 5.5-6.5, and adding water to make up to volume to obtain the mixture.
2. The use according to claim 1, characterized in that: The relative density of the sandalwood oil is 0.944-0.984; the relative density of the galangal oil is 0.873-0.913; the relative density of the asarum oil is 0.962-1.062; and the relative density of the longum longum oil is 0.832-0.892.
